Close
Smartlab Europe
Inizio Ignite

Xyntek forms strategic alliance with Antares Vision

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Smart Factories Driving Innovations in Pharma Industry 4.0

The rise of smart factories in the pharmaceutical sector is characterized by the integration of AI, IoT, and real-time analytics to create highly efficient production ecosystems.

Advanced Process Automation in Biopharma

Modern biopharmaceutical facilities are leveraging advanced automation to enhance the production of complex biologics, ensuring real-time quality control and operational efficiency.

The Role of Digital Transformation in Pharma Manufacturing

Integration of advanced digital technologies into pharmaceutical production is revolutionizing process automation, data integrity, and compliance across the global drug supply chain.
- Advertisement -

Xyntek has entered into a strategic alliance with a provider of e-pedigree and serialization technology and solutions, Antares Vision.

Xyntek is involved in providing real-time automated IT systems and microprocessor based industrial automation solutions to the life sciences industries.

Xyntek president and CEO Mac Hashemian said the strategic partnership with Antares Vision provides the company with the core e-pedigree and serialization technology needed to provide its customers turn-key serialization and e-pedigree solutions.

” Antares Vision has applied its technology to the largest number of installed and operational serialization and aggregation production lines and packages with track and trace applied on a worldwide basis,” Hashemian added.

Antares Vision CEO Emidio Zorzella said the company’s partnership with Xyntek is a strategic and fundamental step to improve its competitiveness in relation to major international players.

“With our joint and mutually exclusive U.S. partnership, together we will become the world’s 1 provider of turn-key e-pedigree, track and trace, serialization, brand security and protection, anti-counterfeiting, and anti-drug diversion solutions,” Zorzella added.

Latest stories

Related stories

Smart Factories Driving Innovations in Pharma Industry 4.0

The rise of smart factories in the pharmaceutical sector is characterized by the integration of AI, IoT, and real-time analytics to create highly efficient production ecosystems.

Advanced Process Automation in Biopharma

Modern biopharmaceutical facilities are leveraging advanced automation to enhance the production of complex biologics, ensuring real-time quality control and operational efficiency.

The Role of Digital Transformation in Pharma Manufacturing

Integration of advanced digital technologies into pharmaceutical production is revolutionizing process automation, data integrity, and compliance across the global drug supply chain.

Green Hydrogen for Sustainable Pharma Plants

Adopting green hydrogen as a primary energy source in pharmaceutical facilities offers a pathway to deep decarbonization, sustainable process heating, and cleaner manufacturing.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »